Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

The9 LTD (NCTY) Form 6-K — Aug 21, 2026

$NCTYForm 6-KFiled Aug 21, 2026, 9:03 AM ET0001104659-26-099420Original filing

Shareholders of RF Acquisition Corp II (Nasdaq: RFAI) voted on August 19, 2026 to approve Nanyang Biologics' proposed business combination, moving the Singapore-based, AI-driven drug discovery company closer to a Nasdaq listing under the reserved ticker "NYB". The9 Limited (Nasdaq: NCTY) holds its NYB stake through wholly owned subsidiary Gamenow.net (Hong Kong) Limited and expects to own approximately 15% to 16% of the combined Nasdaq-listed company upon completion of the deal, which remains subject to customary closing conditions.

Key figures

Reserved ticker
NYB
Shareholder vote date
2026-08-19
Natural compound library size
more than one million natural compounds
Expected stake in combined company
approximately 15% to 16%

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    The9 LTD (NCTY) Form 6-K — Aug 21, 2026: AI Analysis | Signal8